Storytelling With or Without Social Contextual Information in Children With Autistic Spectrum Disorder and Typical Development

October 13, 2020 updated by: Kenneth N. K. Fong, The Hong Kong Polytechnic University

The Effects of Storytelling With or Without Social Contextual Information Regarding Eye Gaze and Visual Attention in Children With Autistic Spectrum Disorder and Typical Development: A Randomized, Controlled Eye-tracking Study

This study was to examine the effects of storytelling with or without contextual information on children with autism spectrum disorder (ASD) and typical development (TD).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This was a 2 x 2 x 2 randomized controlled trial with 52 children (26 with ASD and 26 with TD) recruited in the community and randomized into four groups: 1) ASD Group 1 - storytelling with contextual information; 2) ASD Group 2 - storytelling without contextual information; 3) TD Group 1 - storytelling with contextual information; 4) TD Group 2 - storytelling without contextual information. All stories were photo-based and static in nature. The only difference between Group 1 and Group 2 was that the stories included and did not include social contextual information, respectively. Training was delivered in small groups, with eight sessions across four weeks, two sessions per week, and 30 minutes per session. Participants' total fixation duration (TFD), total visit duration (TVD), and total fixation count (TFC) on human faces from 20 photos and a video were recorded using the Tobii eye tracker.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Hong Kong
      • Hong Kong, Hong Kong
        • The Hong Kong Polytechnic University, Department of Rehabilitation Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria for children with ASD:

  • 1) children aged between 6 and 12 years old;
  • 2) had a previous diagnosis of ASD from medical professionals;
  • 3) studied in mainstream primary school;
  • 4) had a composite IQ score of 80 or above

Inclusion Criteria for children with TD:

  • 1) children aged between 6 and 12 years old;
  • 2) had no developmental disorder or intellectual disability;
  • 3) attended primary school.

Exclusion Criteria:

  • NA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ASD Group 1 - storytelling with social contextual information
Storytelling with social contextual information for children with Autism Spectrum Disorder
Behavioral: Storytelling with social contextual information
Four out of 100 stories from a storytelling app (SAHK, 2013) that incorporated social contextual information, and inter-personal skills were selected. The intervention was in small group format, consisted of eight sessions across four weeks, two sessions per week, 30 minutes per session.
Other: Children with ASD
Four out of 100 stories from a storytelling app (SAHK, 2013) were selected for children with ASD.
Active Comparator: ASD Group 2 - storytelling without social contextual information
Storytelling without social contextual information for children with Autism Spectrum Disorder
Other: Children with ASD
Four out of 100 stories from a storytelling app (SAHK, 2013) were selected for children with ASD.
Behavioral: Storytelling without social contextual information
Four out of 100 stories from a storytelling app (SAHK, 2013) without social contextual information, and inter-personal skills were selected. The intervention was in small group format, consisted of eight sessions across four weeks, two sessions per week, 30 minutes per session.
Experimental: TD Group 1 - storytelling with social contextual information
Storytelling with social contextual information for typically developed children
Behavioral: Storytelling with social contextual information
Four out of 100 stories from a storytelling app (SAHK, 2013) that incorporated social contextual information, and inter-personal skills were selected. The intervention was in small group format, consisted of eight sessions across four weeks, two sessions per week, 30 minutes per session.
Other: Children with TD
Four out of 100 stories from a storytelling app (SAHK, 2013) were selected for children with TD.
Active Comparator: TD Group 2 - storytelling without social contextual information
Storytelling without social contextual information for typically developed children
Behavioral: Storytelling without social contextual information
Four out of 100 stories from a storytelling app (SAHK, 2013) without social contextual information, and inter-personal skills were selected. The intervention was in small group format, consisted of eight sessions across four weeks, two sessions per week, 30 minutes per session.
Other: Children with TD
Four out of 100 stories from a storytelling app (SAHK, 2013) were selected for children with TD.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eye gaze on the eye tracker
Time Frame: Change from baseline to 4 weeks
Total fixation duration (TFD)
Change from baseline to 4 weeks
Eye gaze on the eye tracker
Time Frame: Change from baseline to 4 weeks
Total visit duration (TVD)
Change from baseline to 4 weeks
Eye gaze on the eye tracker
Time Frame: Change from baseline to 4 weeks
Total fixation count (TFC)
Change from baseline to 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trail Making Test
Time Frame: Change from baseline to 4 weeks
Trail Making Test A (TMT-A)
Change from baseline to 4 weeks
Trail Making Test
Time Frame: Change from baseline to 4 weeks
Trail Making Test B (TMT-B)
Change from baseline to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The Hong Kong Polytechnic University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

December 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

October 6, 2020

First Submitted That Met QC Criteria

October 13, 2020

First Posted (Actual)

October 14, 2020

Study Record Updates

Last Update Posted (Actual)

October 14, 2020

Last Update Submitted That Met QC Criteria

October 13, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HSEARS20160427001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Upon request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Storytelling with social contextual information

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe